Cargando…

Lack of Association between YEASTONE Antifungal Susceptibility Tests and Clinical Outcomes of Cryptococcus Meningitis

The relation between antifungal susceptibility and treatment outcomes is not well-characterized. There is paucity of surveillance data for cerebrospinal fluid (CSF) isolates of cryptococcus investigated with YEASTONE colorimetric broth microdilution susceptibility testing. A retrospective study of l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Ting-Shu, Lin, Jung-Fu, Cheng, Chun-Wen, Huang, Po-Yen, Yang, Jeng-How
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963023/ https://www.ncbi.nlm.nih.gov/pubmed/36836346 http://dx.doi.org/10.3390/jof9020232

Ejemplares similares

Identification of Candida species and susceptibility testing with Sensititre YeastOne microdilution panel to 9 antifungal agents
por: Kucukates, Emine, et al.
Publicado: (2016)

Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation
por: Siopi, Maria, et al.
Publicado: (2023)

Antifungal Susceptibilities of Cryptococcus neoformans
por: Archibald, Lennox K., et al.
Publicado: (2004)

Comparison of Two Commercial Colorimetric Broth Microdilution Tests for Candida Susceptibility Testing: Sensititre YeastOne versus MICRONAUT-AM
por: Philips, Sophie, et al.
Publicado: (2021)

Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform
por: Kariyawasam, Ruwandi, et al.
Publicado: (2019)

Methods for Antifungal Susceptibility Testing of the Cryptococcus neoformans/C. gattii Complex: Strengths and Limitations
por: Espinel-Ingroff, Ana, et al.
Publicado: (2023)

In vitro Antifungal Susceptibility Profiles of Cryptococcus neoformans var. grubii and Cryptococcus gattii Clinical Isolates in Guangxi, Southern China
por: Al-Odaini, Najwa, et al.
Publicado: (2021)

The Environmental Effects on Virulence Factors and the Antifungal Susceptibility of Cryptococcus neoformans
por: Momin, Mahek, et al.
Publicado: (2021)

Comparison of the Sensititre YeastOne antifungal method with the CLSI M27-A3 reference method to determine the activity of antifungal agents against clinical isolates of Candida spp.
por: ALTINBAŞ, Rabiye, et al.
Publicado: (2020)

Cryptococcus tetragattii Meningitis Associated with Travel, Taiwan
por: Wu, Pin-Han, et al.
Publicado: (2023)

Genotyping Analysis of Cryptococcus deuterogattii and Correlation with Virulence Factors and Antifungal Susceptibility by the Clinical and Laboratory Standards Institute and the European Committee on Antifungal Susceptibility Testing Methods
por: Andrade-Silva, Leonardo Euripedes, et al.
Publicado: (2023)

Epidemiological and Clinical Characteristics, Antifungal Susceptibility, and MLST-Based Genetic Analysis of Cryptococcus Isolates in Southern Taiwan in 2013–2020
por: Chen, Yi-Chun, et al.
Publicado: (2022)

Molecular types of Cryptococcus species isolated from patients with cryptococcal meningitis in a Brazilian tertiary care hospital
por: Wirth, Fernanda, et al.
Publicado: (2018)

Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India
por: Gutch, Ruchi Sethi, et al.
Publicado: (2015)

Aspergillus Section Terrei and Antifungals: From Broth to Agar-Based Susceptibility Testing Methods
por: Vahedi-Shahandashti, Roya, et al.
Publicado: (2023)

Cryptococcus Meningitis and reversible hearing loss
por: Matos, Janini Oliveira, et al.
Publicado: (2015)

In Vitro Antifungal Susceptibility of Environmental Isolates of Cryptococcus spp. from the West Region of Cameroon
por: Dongmo, William, et al.
Publicado: (2016)

First Isolation, Antifungal Susceptibility, and Molecular Characterization of Cryptococcus neoformans from the Environment in Croatia
por: Pllana-Hajdari, Donjeta, et al.
Publicado: (2019)

Cell Wall Integrity Pathway Involved in Morphogenesis, Virulence and Antifungal Susceptibility in Cryptococcus neoformans
por: de Oliveira, Haroldo Cesar, et al.
Publicado: (2021)

Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against Aspergillus fumigatus and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values
por: Melhem, Marcia S. C., et al.
Publicado: (2022)

Antifungal susceptibility and molecular characteristics of Cryptococcus spp. based on whole-genome sequencing in Zhejiang Province, China
por: Zhang, Junli, et al.
Publicado: (2022)

Novel Antifungal Activity for the Lectin Scytovirin: Inhibition of Cryptococcus neoformans and Cryptococcus gattii
por: Jones, Tyler H., et al.
Publicado: (2017)

Combating increased antifungal drug resistance in Cryptococcus, what should we do in the future? : Antifungal drug resistance in Cryptococcus
por: Deng, Hengyu, et al.
Publicado: (2023)

Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities
por: Matos, C. S., et al.
Publicado: (2012)

Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility
por: Krysan, Damian J., et al.
Publicado: (2019)

829. 5-Flucytosine Longitudinal Antifungal Susceptibility Testing of Cryptococcus neoformans: A Sub-study of the EnACT Trial Testing Oral Amphotericin
por: McHale, Thomas, et al.
Publicado: (2023)

The Cryptococcus neoformans Transcriptome at the Site of Human Meningitis
por: Chen, Yuan, et al.
Publicado: (2014)

Antifungal activity of liriodenine on clinical strains of Cryptococcus neoformans and Cryptococcus gattii species complexes
por: Levorato-Vinche, Adriele Dandara, et al.
Publicado: (2022)

Microsatellite typing and susceptibilities of serial Cryptococcus neoformans isolates from Cuban patients with recurrent cryptococcal meningitis
por: Illnait-Zaragozí, María T, et al.
Publicado: (2010)

Lack of Cryptococcus gattii from Eucalyptus in Ahvaz
por: Salehei, Z, et al.
Publicado: (2015)

Rostered Routine Testing: A Necessary Evil?
por: Tan, Seow Yen, et al.
Publicado: (2021)

Cryptococcus gattii Meningitis Complicated by Listeria monocytogenes Infection
por: Deiss, Robert G., et al.
Publicado: (2016)

Cryptococcus laurentii meningitis in a non-HIV patient()
por: Castro-Lainez, Miriams T., et al.
Publicado: (2019)

Meningitis Caused by Cryptococcus neoformans in an Apparently Immunocompetent Patient
por: Shokouhi, Shervin, et al.
Publicado: (2022)

Interactions between antifungals and everolimus against Cryptococcus neoformans
por: Liang, Pin, et al.
Publicado: (2023)

ANTIFUNGAL SUSCEPTIBILITY TESTING AND GENOTYPING CHARACTERIZATION OF Cryptococcus neoformans AND gattii ISOLATES FROM HIV-INFECTED PATIENTS OF RIBEIRÃO PRETO, SÃO PAULO, BRAZIL
por: FIGUEIREDO, Thais Pandini, et al.
Publicado: (2016)

Investigation of Antifungal Mechanisms of Thymol in the Human Fungal Pathogen, Cryptococcus neoformans
por: Jung, Kwang-Woo, et al.
Publicado: (2021)

Cryptococcus neoformans Causing Meningoencephalitis in Adults and a Child from Lima, Peru: Genotypic Diversity and Antifungal Susceptibility
por: Firacative, Carolina, et al.
Publicado: (2022)

Antifungal and Anti-Biofilm Activity of Essential Oil Active Components against Cryptococcus neoformans and Cryptococcus laurentii
por: Kumari, Poonam, et al.
Publicado: (2017)

Cryptococcus neoformans–Specific and Non–Cryptococcus neoformans–Specific Antibody Profiles in Organ Transplant Recipients With and Without Cryptococcosis
por: Yoon, Hyunah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7934pakofsgsdndg0gr5rhbqm3